PLoS launches new collection on control, elimination of human helminthiases

Apr 26 2012

"The April 2012 issue of PLoS Neglected Tropical Diseases features the launch of a new collection, 'A research agenda for the control and elimination of human helminthiases,'" the PLoS "Speaking of Medicine" blog reports. According to the blog, "The collection includes a series of eight reviews from the Disease Reference Group on Helminth Infections (DRG4) that, taken together, outline a research and development (R&D) agenda for the control and elimination of helminth diseases of humans" (4/24).

    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Medical Research News | Disease/Infection News

    Tags: , , ,

    Comments (0)

    Suggested Reading

    Aircraft noise pollution harms arteries, but heart drugs show promise in animal model research
    Decades of research push cytomegalovirus vaccine closer to reality
    New research explores hidden health risks of hereditary hemochromatosis
    Being fit matters more than weight for long-term health, research shows
    Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy
    Research uncovers dietary patterns influencing Mediterranean Diet adherence
    Heart health benefits soar with regular sleep schedules, research finds
    New research identifies metabolic targets to combat antibiotic-resistant bacterial infections

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    (Logout)
    Post

    Newsletters you may be interested in

    See all Newsletters »

    Terms

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    Provide Feedback

    You might also like...
    AstraZeneca's Pioneering Research in Heart Failure and ATTR-CM